Neurone Studio (NRS) 주식 개요Neurone Studio S.A.는 폴란드에서 컴퓨터 게임을 제작 및 퍼블리싱하는 회사입니다. 자세히 보기NRS 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성6/6배당0/6강점공정 가치 추정치보다 낮은 33.3% 에서 거래지난 5년 동안 수입이 매년 23.4% 증가했습니다.위험 분석주식은 유동성이 매우 낮습니다의미 있는 시가총액이 없습니다(PLN3M)수익이 USD$1m 미만입니다(PLN0)지난 1년 동안 주주가 희석되었습니다.모든 위험 점검 보기NRS Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValuezłCurrent Pricezł0.94해당 없음내재 할인율Est. Revenue$PastFuture-2m204k2016201920222025202620282031Revenue zł0.01Earnings zł0.002AdvancedSet Fair ValueView all narrativesNeurone Studio S.A. 경쟁사Kool2playSymbol: WSE:K2PMarket cap: zł2.5mMadmind Studio Spólka AkcyjnaSymbol: WSE:MMSMarket cap: zł4.8mDraw DistanceSymbol: WSE:DDIMarket cap: zł1.7mT-BullSymbol: WSE:TBLMarket cap: zł2.9m가격 이력 및 성과Neurone Studio 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가zł0.9452주 최고가zł1.7152주 최저가zł0.94베타0.441개월 변동0%3개월 변동n/a1년 변동n/a3년 변동n/a5년 변동-70.06%IPO 이후 변동-84.62%최근 뉴스 및 업데이트공시 • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026분석 기사 • Jan 04A Look At The Fair Value Of Neurone Studio S.A. (WSE:NRS)Key Insights Using the 2 Stage Free Cash Flow to Equity, Neurone Studio fair value estimate is zł1.30 With zł1.20 share...Buy Or Sell Opportunity • Dec 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to zł1.02. The fair value is estimated to be zł1.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.Buy Or Sell Opportunity • Dec 01Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to zł1.10. The fair value is estimated to be zł1.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 24%.공시 • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Shares are highly illiquid. Revenue is less than US$1m. Market cap is less than US$10m (zł3.87m market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).더 많은 업데이트 보기Recent updates공시 • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026분석 기사 • Jan 04A Look At The Fair Value Of Neurone Studio S.A. (WSE:NRS)Key Insights Using the 2 Stage Free Cash Flow to Equity, Neurone Studio fair value estimate is zł1.30 With zł1.20 share...Buy Or Sell Opportunity • Dec 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to zł1.02. The fair value is estimated to be zł1.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.Buy Or Sell Opportunity • Dec 01Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to zł1.10. The fair value is estimated to be zł1.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 24%.공시 • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Shares are highly illiquid. Revenue is less than US$1m. Market cap is less than US$10m (zł3.87m market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).New Risk • Sep 06New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł213k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Shares are highly illiquid. Revenue is less than US$1m. Market cap is less than US$10m (zł2.85m market cap, or US$786.9k).New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Shares are highly illiquid. Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (zł3.51m market cap, or US$868.5k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).공시 • Jun 18Neurone Studio S.A., Annual General Meeting, Jul 11, 2024Neurone Studio S.A., Annual General Meeting, Jul 11, 2024.공시 • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024New Risk • Aug 25New major risk - Negative shareholders equityThe company has negative equity. Total equity: -zł6.8k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł329k free cash flow). Shares are highly illiquid. Negative equity (-zł6.8k). Revenue is less than US$1m (zł250 revenue, or US$60.0). Market cap is less than US$10m (zł4.39m market cap, or US$1.06m). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).공시 • Jun 04Neurone Studio S.A., Annual General Meeting, Jun 30, 2023Neurone Studio S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time.공시 • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023Is New 90 Day High Low • Feb 12New 90-day low: zł3.70The company is down 21% from its price of zł4.70 on 13 November 2020. The Polish market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is down 17% over the same period.Is New 90 Day High Low • Oct 21New 90-day low: zł4.74The company is down 18% from its price of zł5.75 on 23 July 2020. The Polish market is down 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is down 3.0% over the same period.주주 수익률NRSPL EntertainmentPL 시장7D0%0.2%1.0%1Yn/a8.7%25.1%전체 주주 수익률 보기수익률 대 산업: NRS의 Polish Entertainment 산업 대비 성과를 판단하기에 데이터가 부족합니다.수익률 대 시장: NRS의 Polish 시장 대비 성과를 판단하기에 데이터가 부족합니다.주가 변동성Is NRS's price volatile compared to industry and market?NRS volatilityNRS Average Weekly Movementn/aEntertainment Industry Average Movement5.0%Market Average Movement5.3%10% most volatile stocks in PL Market10.6%10% least volatile stocks in PL Market3.1%안정적인 주가: NRS의 주가는 지난 3개월 동안 Polish 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine NRS의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트2016n/aDawid Modrowww.neuronestudio.pl뉴론 스튜디오는 폴란드에서 컴퓨터 게임을 제작 및 퍼블리싱하는 회사입니다. IT 소프트웨어를 개발합니다. 이 회사는 이전에 허클베리 게임즈 S.A.로 알려졌으나 2020년 10월에 뉴론 스튜디오 S.A.로 사명을 변경했습니다.더 보기Neurone Studio S.A. 기초 지표 요약Neurone Studio의 순이익과 매출은 시가총액과 어떻게 비교됩니까?NRS 기초 통계시가총액zł2.60m순이익 (TTM)-zł208.22k매출 (TTM)n/a0.0x주가매출비율(P/S)-12.5x주가수익비율(P/E)NRS는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표NRS 손익계산서 (TTM)매출zł0매출원가zł0총이익zł0기타 비용zł208.22k순이익-zł208.22k최근 보고된 실적Sep 30, 2025다음 실적 발표일May 29, 2026주당순이익(EPS)-0.075총이익률0.00%순이익률0.00%부채/자본 비율0%NRS의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 16:40종가2026/03/18 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Neurone Studio S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
분석 기사 • Jan 04A Look At The Fair Value Of Neurone Studio S.A. (WSE:NRS)Key Insights Using the 2 Stage Free Cash Flow to Equity, Neurone Studio fair value estimate is zł1.30 With zł1.20 share...
Buy Or Sell Opportunity • Dec 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to zł1.02. The fair value is estimated to be zł1.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
Buy Or Sell Opportunity • Dec 01Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to zł1.10. The fair value is estimated to be zł1.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 24%.
공시 • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025
New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Shares are highly illiquid. Revenue is less than US$1m. Market cap is less than US$10m (zł3.87m market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).
공시 • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
분석 기사 • Jan 04A Look At The Fair Value Of Neurone Studio S.A. (WSE:NRS)Key Insights Using the 2 Stage Free Cash Flow to Equity, Neurone Studio fair value estimate is zł1.30 With zł1.20 share...
Buy Or Sell Opportunity • Dec 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to zł1.02. The fair value is estimated to be zł1.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
Buy Or Sell Opportunity • Dec 01Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to zł1.10. The fair value is estimated to be zł1.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 24%.
공시 • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025
New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Shares are highly illiquid. Revenue is less than US$1m. Market cap is less than US$10m (zł3.87m market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).
New Risk • Sep 06New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł213k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Shares are highly illiquid. Revenue is less than US$1m. Market cap is less than US$10m (zł2.85m market cap, or US$786.9k).
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Shares are highly illiquid. Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (zł3.51m market cap, or US$868.5k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
공시 • Jun 18Neurone Studio S.A., Annual General Meeting, Jul 11, 2024Neurone Studio S.A., Annual General Meeting, Jul 11, 2024.
공시 • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
New Risk • Aug 25New major risk - Negative shareholders equityThe company has negative equity. Total equity: -zł6.8k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł329k free cash flow). Shares are highly illiquid. Negative equity (-zł6.8k). Revenue is less than US$1m (zł250 revenue, or US$60.0). Market cap is less than US$10m (zł4.39m market cap, or US$1.06m). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).
공시 • Jun 04Neurone Studio S.A., Annual General Meeting, Jun 30, 2023Neurone Studio S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time.
공시 • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023
Is New 90 Day High Low • Feb 12New 90-day low: zł3.70The company is down 21% from its price of zł4.70 on 13 November 2020. The Polish market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is down 17% over the same period.
Is New 90 Day High Low • Oct 21New 90-day low: zł4.74The company is down 18% from its price of zł5.75 on 23 July 2020. The Polish market is down 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is down 3.0% over the same period.
